טוען...
Correlates of metastatic melanoma response to checkpoint inhibition
Immunotherapy for metastatic melanoma has a decades-long history, and the relatively recent use of checkpoint inhibitors has revolutionized treatment. Durable, and sometimes complete, remission of metastatic melanoma is now achievable in some patients receiving checkpoint-blocking therapy. However,...
שמור ב:
| הוצא לאור ב: | Cancer |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5445935/ https://ncbi.nlm.nih.gov/pubmed/28543699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30444 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|